CSR Report

Overview

The report describes how the Miraca Group creates healthcare value through clinical laboratory testing and in vitro diagnostics. It defines 16 material issues across society, human resources, environment, local communities, and business foundations, with final agreement by the Miraca Holdings Executive Committee. The report also presents consolidated net sales of 195.4 billion yen for the year ended March 31, 2018 and discloses Group-wide Scope 1, Scope 2, and selected Scope 3 emissions.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2018
Period: 1 April 2017 – 31 July 2018
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services